Radiation therapy for age-related macular degeneration.
Neovascular age-related macular degeneration is the most common cause of severe irreversible blindness in the Western world in people older than age 50. Laser photocoagulation is the only proven treatment for this disease; however, fewer than 20% of patients are eligible for this treatment because the majority of choroidal neovascularization membranes are not visible by ophthalmoscopy or angiography. In addition, many patients elect not to undergo this treatment because laser treatment of subfoveal neovascular membranes results in immediate and permanent central visual loss. Several treatments are under investigation, including external-beam radiation therapy. There are multiple publications of early trials using radiation therapy, but to date there is only one randomized published study. This article reviews these trials and summarizes the status of radiation therapy as a treatment for macular degeneration.
Berson
A M
AM
Department of Radiation Oncology, Saint Vincent's Comprehensive Cancer Center, New York, NY 10011, USA.
Finger
P T
PT
Chakravarthy
U
U
D000368:Aged; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D008268:Macular Degeneration / Q000532:radiotherapy*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic